Responses
Clinical and epidemiological research
Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 17 January 2013
- Published on: 17 January 2013Step up therapy remains an appropriate optionShow More
Dear Editor,
I congratulate the research team from Rotterdam for the high quality study design of the tREACH study, but their conclusions are over-stated [1]. Their quotation of the literature is incomplete, referring to studies that have studied initial combination DMARDs plus corticosteroid (BeSt, FinRACo, COBRA) but excluding those studies that do not support their conclusions. There have been two previously publ...
Conflict of Interest:
None declared.